iMeta (Jun 2025)

Efficacy and biomarker analysis of neoadjuvant disitamab vedotin (RC48‐ADC) combined immunotherapy in patients with muscle‐invasive bladder cancer: A multi‐center real‐world study

  • Jiao Hu,
  • Luzhe Yan,
  • Jinhui Liu,
  • Minfeng Chen,
  • Peihua Liu,
  • Dingshan Deng,
  • Chaobin Zhang,
  • Yunbo He,
  • Benyi Fan,
  • Huihuang Li,
  • Guanghui Gong,
  • Jiatong Xiao,
  • Ruizhe Wang,
  • Xiao Guan,
  • Shiyu Tong,
  • Yangle Li,
  • Nannan Li,
  • Zhiwang Tang,
  • Teng Zhang,
  • Hao Li,
  • Bin Huang,
  • Ning Gao,
  • Wei He,
  • Zhiyong Cai,
  • Yifan Liu,
  • Zefu Liu,
  • Yu Gan,
  • Yu Cui,
  • Yuanqing Dai,
  • Yi Cai,
  • Zhenyu Nie,
  • Zhenyu Ou,
  • Jinbo Chen,
  • Xiongbing Zu

DOI
https://doi.org/10.1002/imt2.70033
Journal volume & issue
Vol. 4, no. 3
pp. n/a – n/a

Abstract

Read online

No abstracts available.